Given the importance of TNFα in IBD pathogenesis, the increasing use of anti-TNFα therapy to control the disease, and the risk of tuberculosis associated with such therapy [41], it will be important to determine if TNFα has inhibitory effects on hepcidin expression in human IBD. Here, HAMP is linked to inflammatory bowel disease.